FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease ...Middle East

TAIPEI, Oct. 23, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and bulbar muscular atrophy (SBMA, also known as...

Hence then, the article about fda grants fast track designation for aj201 a first in class therapy for kenndy s disease was published today ( Thursday 23/10/2025 - 07:22 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease )

Also on site :

• Pop Star Makes Streaming History with Record-Breaking Third Album Just One Day After Release
• Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak -- Product Sold Nationwide at Target
• UK and Japan poised to seal landmark £18 billion investment deal to create thousands of jobs